GlassScriptPhysician profile
Smeet Patel
NPI 1558758987
$3,286.94
in general payments reported to CMS, 2019-2025
32 companies · $626 in 2025
The $626 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $110 · 2021: $294 · 2022: $193 · 2023: $1,151 · 2024: $913 · 2025: $626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,271 · Travel and Lodging: $419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,270.77 |
| Travel and Lodging | $419.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $677.68 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| W. L. Gore & Associates, INC. | $247.52 | 2023-2024 | Gore Tag Conformable Thoracic Stent Graft, Gore Enform Preperitoneal Biomaterial, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Novo Nordisk INC | $228.79 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Neurocrine Biosciences, INC. | $210.69 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $195.48 | 2021-2025 | Farxiga, Airsupra |
| Abbvie INC. | $194.45 | 2023-2025 | |
| Lundbeck LLC | $179.74 | 2024-2025 | Rexulti |
| Glaxosmithkline, LLC. | $132.31 | 2020-2023 | Trelegy Ellipta |
| Otsuka America Pharmaceutical, INC. | $131.98 | 2020-2025 | Rexulti |
| Heron Therapeutics, INC. | $121.84 | 2025 | Zynrelef, Aponvie |
| Alkermes, INC. | $93.16 | 2025 | Aristada, Lybalvi |
| Lilly USA, LLC | $90.64 | 2023 | Mounjaro, Trulicity |
| Argon Medical Devices, INC. | $76.86 | 2024 | Clot Management |
| Vanda Pharmaceuticals INC. | $75.36 | 2021-2024 | Fanapt, Hetlioz |
| Dexcom, INC. | $69.64 | 2023 | Dexcom G6 Transmitter |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $64.77 | 2021-2025 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $57.58 | 2024-2025 | Trintellix |
| Teva Pharmaceuticals USA, INC. | $56.13 | 2021 | |
| Idorsia Pharmaceuticals US INC | $48.14 | 2023-2024 | Quviviq |
| Cardiva Medical, INC. | $41.04 | 2020-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Eisai INC. | $36.31 | 2020 | |
| Exact Sciences Corporation | $35.14 | 2023 | Cologuard Collection Kit |
| Jazz Pharmaceuticals INC. | $32.09 | 2021 | |
| Pfizer INC. | $30.29 | 2022 | |
| Inogen, INC. | $26.29 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Boston Scientific Corporation | $23.48 | 2023 | Sq-Rx Pulse Generator |
| Shockwave Medical, INC | $22.97 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Phathom Pharmaceuticals, INC. | $20.31 | 2025 | Voquezna |
| Lucid Diagnostics INC. | $20.16 | 2023 | |
| Janssen Pharmaceuticals, INC | $19.90 | 2025 | Spravato |
| Biohaven Pharmaceutical Holding Company LTD. | $14.61 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $11.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Smeet Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.